<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Di Biase, Luigi</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">TEE Unnecessary Prior to Ablation for AF With NOACs</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-07 11:12:17</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-11</style></pages><abstract><style  face="normal" font="default" size="100%">According to a multicenter, prospective registry study, patients with AF can safely undergo radiofrequency catheter ablation while continuing apixaban or rivaroxaban without undergoing prior transesophageal echocardiography. Among patients who did not undergo transesophageal echocardiography, there was no evidence of left atrial appendage thrombosis, and less than half had “smoke” on intracardiac echocardiography.</style></abstract><number><style face="normal" font="default" size="100%">22</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>